Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Instagram Outage Disrupts Thousands of U.S. Users 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
, a range of dry surrogate microorganisms - EconoTimes)
DIJON, France, Oct. 07, 2016 -- Novolyze, a fast-growing food biotechnology company, announces the global launch of its new range of products: SurroNov(TM) www.novolyze.com
SurroNov(TM) is a range of innovative surrogate microorganisms that mimic the behavior of food pathogens (Salmonella, Listeria, Cronobacter sakazakii etc). As they are non-pathogenic, SurroNov(TM) products can be directly used in-plant to validate the efficacy of preventive controls on the microbial reduction of food products.
The range was officially presented at IAFP Annual Meeting in St. Louis. MO from July 29 to August 4, 2016. The first surrogate introduced is a strain used for the validation of low water activity foods (spices, nuts, powders, pet food etc) for which the prevention and control of microbiological hazards is a key food safety challenge. Our surrogate has been tested on numerous food processes, most of them thermal processes such as extruders, dryers, roasters and ovens. The first projects performed using SurroNov(TM) products showed highly correlative results, confirming the strong interest of the food industry for stabilized, dry & ready to use surrogate microorganisms.
The launch of SurroNov(TM) is an important step for Novolyze: It is the result of several years of R&D as well as intensive financial and human capital investments. SurroNov(TM) products are patented innovations based on Novolyze Dry Surrogate Technology. In parallel, the company continues its development plan, focused on the research of new strains for different kinds of food products.
Jena Robers, VP Business Development at Novolyze : 'First collaborations with several multinational food companies have been initiated and we are proud that our innovations received such a positive feedback. We are convinced that SurroNov(TM) surrogate microorganisms are a key tool for food companies to comply with FSMA Final Rule for Preventive Controls for Human Food. Our team is now focused on the evolution of the range and on the launch of other strains to complete our portfolio. Our ambition is to offer innovative solutions to our partners in order to better control microbiological hazards and improve food safety of processed foods.'
Contact :
Pierre-Olivier BEAL Business Development Manager
T (USA) : +1 (617) 500-8536
www.novolyze.com
